HENDERSON, Nev., July 27, 2007 (PRIME NEWSWIRE) -- BodyTel Scientific, Inc. (OTCBB:BDYT), a company focused on the development of innovative wireless healthcare products, today announced that they will be attending the American Association of Diabetes Educators' (AADE) 34th annual meeting and exhibition August 1-4, 2007. BodyTel management will be exhibiting conforming samples of its GlucoTel Meter at booth 2238 at the America's Center in St. Louis, Missouri.
The GlucoTel Meter is the first and only blood glucose monitoring device in the world with integrated Bluetooth(tm) technology. The meter is part of the GlucoTel system, a complete telemedical diabetes self-management system supporting patients and doctors in the treatment of diabetes. The GlucoTel blood glucose meter collects blood sugar readings and transmits it automatically via Bluetooth to the patient's mobile phone. The data is then sent via SMS (text message) or GPRS (data package) to an Internet database and stored long-term.
The 34th Annual Meeting and Exhibition is a gathering of educational and healthcare professionals founded to introduce innovative approaches to diabetes self-management, explore new tools that improve outcomes, and uncover valuable resources. The AADE is committed to helping patients with diabetes identify barriers, facilitate problem-solving, and develop skills to live healthier, more productive lives.
Stefan Schraps, CEO of BodyTel Scientific, commented, "Diabetes educators specialize in the treatment of diabetes. It's from these professionals that patients learn when and how to treat and manage this disease. Our Glucotel system allows for easy and accurate monitoring of a patient's glucose level and should be well received by professionals looking to recommend the latest in diabetes monitoring. This event is an ideal venue to educate healthcare professionals about the benefits of our truly innovative device."
Established in 1973, the American Association of Diabetes Educators is a multidisciplinary professional membership organization of 12,000 healthcare professionals dedicated to integrating successful self-management as a key outcome in the care of people with diabetes and related conditions.
Attendance at the conference is expected to approach 4,000 diabetes educators and healthcare professionals. At the AADE, Educators evaluate and decide the products and services they will recommend to their patients with diabetes.
About BodyTel Scientific, Inc.
BodyTel Scientific, Inc. is a company focused on the development of innovative wireless health monitoring products. Please visit www.bodytel.com for more company information.
Forward-Looking Statements
Statements regarding the Company's business which are not historical facts are "forward-looking statements" that involve risks and uncertainties that could cause actual results to differ materially from the potential results discussed in the forward-looking statements. Forward-looking statements in this press release include that the GlucoTel Meter is the first and only blood glucose monitoring device in the world with integrated Bluetooth(TM) technology. The meter is part of the GlucoTel system, a complete telemedical diabetes self-management system supporting patients and doctors in the treatment of diabetes, our Glucotel system allows for easy and accurate monitoring of a patient's glucose level and should be well received by professionals looking to recommend the latest in diabetes monitoring, and that this event is an ideal venue to educate healthcare professionals about the benefits of our truly innovative device. Actual results may differ materially from those currently anticipated due to a number of factors as we may find that our products must compete with cheaper or better products; we may not be able to retain key employees; a bigger market may not develop for our products and we may not be able to continue to attract new customers; we may face litigation if our technology fails to work when required; our intellectual property may be attacked and defeated in court proceedings; our patent and FDA/CE filings may be rejected by the patent offices and regulators; other companies may discover and develop better or cheaper technologies that would render our products obsolete and we may not have sufficient funding to further develop and/or market our technology. Readers are directed to the BodyTel Scientific, Inc.'s reports as filed with the U.S. Securities and Exchange Commission from time to time, including but not limited to its 8-K filed December 14, 2006 under our prior name Sellcell.net which outlined the company's current business for further information and factors that may affect BodyTel Scientific Inc.'s business and results of operations as well as the Company's form 10-KSB filed on December 15, 2006 and the Company's form 10-QSB filed on January 16, 2007. BodyTel Scientific Inc. undertakes no obligations to publicly update any forward-looking statements to reflect future events or circumstances.